Back to results

University of Cambridge

Protein engineering of botulinum toxins with enhanced ganglioside binding capacity A biophysical and computational approach

Abstract

dc:description.abstract

Botulinum toxins (BoNTs) comprise a family of extremely potent neurotoxins, which have been harnessed as muscle relaxants for the treatment of a wide variety of debilitating diseases, particularly for the treatment of movement disorders. BoNT entry into neurons leads to destructive cleavage of cellular proteins critical to vesicle fusion and neurotransmitter release at the neuromuscular junction. A dual receptor model has been proposed for BoNT binding to target neurons, comprising a low affinity ganglioside interaction followed by a higher affinity interaction with a protein receptor. A deeper understanding of the molecular nature of these interactions will facilitate the generation of modified BoNT proteins with novel characteristics and significant therapeutic potential. This project was aimed principally at molecular characterisation of the interaction of BoNT/A with gangliosides, using a combination of computational, biochemical, and biophysical methods. Specific achievements included: 1) The development and optimisation of two biophysical protocols for measuring Botulinum neurotoxin binding to gangliosides. 2) The preparation of a well curated carbohydrate database that contained all known structures of protein-carbohydrate. 3) The generation of a comprehensive and meaningful benchmark for algorithms that are designed to predict affinity values for protein-small molecule interactions. 4) The training of a state-of-the-art machine learning algorithm that can predict affinity values for protein-small molecule interactions. 5) The use of computational and biophysical approaches to explore the specificity and selectivity of ganglioside binding pockets. The objective was to make contributions to the development of an engineered BoNT with novel binding properties and therapeutic potential. In addition, a set of novel tools and methodologies that can be applied across most types of structural data was developed. In addition to the main project this thesis describes a series of collaborative efforts, not directly related to BoNTs, that were undertaken during my PhD. This section focuses mainly on projects related to the COVID-19 pandemic, which heavily disrupted ordinary research work, as well as a parallel project modelling the proteome of Mycobacterium abscessus.

Degree

thesis:*
Name dc:type.qualificationname
Doctor of Philosophy (PhD)
Level dc:type.qualificationlevel
Doctoral
Grantor dc:publisher.institution
University of Cambridge
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Copoiu, Liviu
Advisor dc:contributor.advisor
  • Blundell, Thomas Leon

Subjects

dc:subject × 5

Rights

dc:rights
Language dc:language
eng

Identifiers

dc:identifier.*
Author Identifier
0000-0001-9329-114X
OAI identifier oai:identifier
oai:www.repository.cam.ac.uk:1810/342216

Chain of custody

source
Harvested from
Cambridge University
Base URL
api.repository.cam.ac.uk/server/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Copoiu, Liviu. Protein engineering of botulinum toxins with enhanced ganglioside binding capacity A biophysical and computational approach. Doctoral thesis, University of Cambridge, 2021. https://doi.org/10.17863/CAM.89635